Renal Cancer - Results from #2920

Three-dimensional nephrometry scoring system: a precise scoring system to evaluate complexity of renal tumors suitable for partial nephrectomy. March 16, 2020

Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis. March 16, 2020

Choice of Surgical Options in Kidney Cancer and Surgical Complications. March 13, 2020

Management of Patients With Metastatic Renal Cell Cancer and Bone Metastases. March 13, 2020

Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma. March 13, 2020

Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma. March 12, 2020

Tumor necrosis factor receptor-2 signaling pathways promote survival of cancer stem-like CD133+ cells in clear cell renal carcinoma. March 12, 2020

Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors. March 12, 2020

The Importance of Nephropathology in Kidney Cancer. March 11, 2020

Discovery and validation of the prognostic value of the lncRNAs encoding snoRNAs in patients with clear cell renal cell carcinoma. March 11, 2020

Modeling clear cell renal cell carcinoma and therapeutic implications. March 11, 2020

Immune Checkpoint Inhibitors in the Treatment of Renal Cell Carcinoma. March 10, 2020

The Therapeutic Landscape of Renal Cell Carcinoma: From the Dark Age to the Golden Age. March 10, 2020

The role of active surveillance and cytoreductive nephrectomy in metastatic renal cell carcinoma. March 10, 2020

Potential New Therapeutic Approaches for Renal Cell Carcinoma. March 9, 2020

Patient-reported outcomes from the phase 3 randomized IMmotion151 trial: atezolizumab + bevacizumab vs sunitinib in treatment-naive metastatic renal cell carcinoma. March 9, 2020

TBK1 Activation by VHL Loss in Renal Cell Carcinoma: A Novel HIF-Independent Vulnerability. March 9, 2020

Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma Patients. March 6, 2020

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma. March 6, 2020

Metatarsal metastasis from clear cell renal cell carcinoma: a case report and literature review. March 6, 2020

Page 147 of 456